Sun Pharma recovers from previous session’s drubbing

14 Mar 2014 Evaluate

Sun Pharmaceutical Industries is currently trading at Rs. 577.80, up by 4.20 points or 0.73 % from its previous closing of Rs. 573.60 on the BSE.

The scrip opened at Rs. 571.45 and has touched a high and low of Rs. 580.00 and Rs. 552.50 respectively. So far 360386 shares were traded on the counter.

The BSE group 'A' stock of face value Re. 1 has touched a 52 week high of Rs. 653.10 on 03-Mar-2014 and a 52 week low of Rs. 405.50 on 01-Apr-2013.

Last one week high and low of the scrip stood at Rs. 625.60 and Rs. 565.60 respectively. The current market cap of the company is Rs. 119713.27 crore.

The promoters holding in the company stood at 63.65 % while Institutions and Non-Institutions held 28.23 % and 8.11 % respectively

 The United States Food and Drug Administration (US FDA) has imposed an import alert, effectively a ban, on generic drug-maker Sun Pharmaceutical Industries’ plant in Gujarat. The plant at Karkhadi in Gujarat makes both drug ingredients and formulations.

An ‘import alert’ results in the detention without physical examination of drugs from firms that have not met so-called good manufacturing practices.

Recently, the company’s subsidiary Caraco received US FDA approval for Risperidone oral tablets. The oral tablet is used for the treatment of schizophrenia (a mental disorder).

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×